World congress on insulin resistance, diabetes, and cardiovascular disease: Part 1.
作者信息
Bloomgarden Zachary T
机构信息
Division of Endocrinology, Mount Sinai School of Medicine, New York, New York, USA.
出版信息
Diabetes Care. 2011 Jul;34(7):e115-120. doi: 10.2337/dc11-0840.
Abstract
摘要
相似文献
1
World congress on insulin resistance, diabetes, and cardiovascular disease: Part 1.胰岛素抵抗、糖尿病与心血管疾病世界大会：第1部分
Diabetes Care. 2011 Jul;34(7):e115-120. doi: 10.2337/dc11-0840.
2
In vivo actions of peroxisome proliferator-activated receptors: glycemic control, insulin sensitivity, and insulin secretion.过氧化物酶体增殖物激活受体的体内作用：血糖控制、胰岛素敏感性及胰岛素分泌。
Diabetes Care. 2013 Aug;36 Suppl 2(Suppl 2):S162-74. doi: 10.2337/dcS13-2003.
3
Insulin resistance--a common link between type 2 diabetes and cardiovascular disease.胰岛素抵抗——2型糖尿病与心血管疾病之间的共同关联。
Diabetes Obes Metab. 2006 May;8(3):237-49. doi: 10.1111/j.1463-1326.2005.00521.x.
4
PPAR agonists: multimodal drugs for the treatment of type-2 diabetes.过氧化物酶体增殖物激活受体激动剂：用于治疗2型糖尿病的多模式药物。
Best Pract Res Clin Endocrinol Metab. 2007 Dec;21(4):687-710. doi: 10.1016/j.beem.2007.09.004.
5
[The role of PPARs and their isoforms in metabolic disorders related to insulin resistance and diabetes].[过氧化物酶体增殖物激活受体（PPARs）及其亚型在与胰岛素抵抗和糖尿病相关的代谢紊乱中的作用]
Tsitol Genet. 2011 May-Jun;45(3):68-78.
6
[Uric acid metabolism and insulin resistance in type 2 diabetes].
Nihon Rinsho. 2002 Aug;60 Suppl 8:167-72.
7
Peroxisome proliferator activated receptor ligands for the treatment of insulin resistance.用于治疗胰岛素抵抗的过氧化物酶体增殖物激活受体配体。
Curr Opin Investig Drugs. 2004 Oct;5(10):1045-50.
8
Role of insulin resistance in the pathophysiology of non-insulin dependent diabetes mellitus.胰岛素抵抗在非胰岛素依赖型糖尿病病理生理学中的作用。
Diabetes Metab Rev. 1993 Nov;9 Suppl 1:5S-12S. doi: 10.1002/dmr.5610090503.
9
Peroxisome proliferator-activated receptor (PPAR) in metabolic syndrome and type 2 diabetes mellitus.过氧化物酶体增殖物激活受体（PPAR）与代谢综合征和2型糖尿病
Curr Diabetes Rev. 2007 Feb;3(1):33-9. doi: 10.2174/157339907779802067.
10
Efficacy of peroxisome proliferator-activated receptor agonists in diabetes and coronary artery disease.过氧化物酶体增殖物激活受体激动剂在糖尿病和冠状动脉疾病中的疗效。
Curr Atheroscler Rep. 2009 Jul;11(4):281-8. doi: 10.1007/s11883-009-0043-5.
引用本文的文献
1
Diabetes and atherothrombosis: The circadian rhythm and role of melatonin in vascular protection.糖尿病与动脉血栓形成：褪黑素的昼夜节律及其在血管保护中的作用。
Diab Vasc Dis Res. 2020 Mar-Apr;17(3):1479164120920582. doi: 10.1177/1479164120920582.
2
Depression as an Immunometabolic Disorder: Exploring Shared Pharmacotherapeutics with Cardiovascular Disease.抑郁症作为一种免疫代谢疾病：探索与心血管疾病的共同药物治疗方法。
Curr Neuropharmacol. 2020;18(11):1138-1153. doi: 10.2174/1570159X18666200413144401.
3
Interaction between IGFBP7 and insulin: a theoretical and experimental study.胰岛素样生长因子结合蛋白7（IGFBP7）与胰岛素之间的相互作用：一项理论与实验研究。
Sci Rep. 2016 Apr 22;6:19586. doi: 10.1038/srep19586.
4
Early life exposure to fructose and offspring phenotype: implications for long term metabolic homeostasis.生命早期接触果糖与后代表型：对长期代谢稳态的影响
J Obes. 2014;2014:203474. doi: 10.1155/2014/203474. Epub 2014 Apr 23.
5
Proinflammatory and prothrombotic state in subjects with different glucose tolerance status before cardiovascular disease.心血管疾病发生前不同糖耐量状态受试者的促炎和促血栓形成状态
J Diabetes Res. 2014;2014:631902. doi: 10.1155/2014/631902. Epub 2014 Mar 17.
6
Stress eating and health. Findings from MIDUS, a national study of US adults.压力性进食与健康。来自美国成年人全国性研究 MIDUS 的发现。
Appetite. 2013 Oct;69:151-5. doi: 10.1016/j.appet.2013.05.020. Epub 2013 Jun 6.
7
Synergistic effect of neuroticism and body mass index on glucose metabolism in nondiabetic adults.神经质与体重指数对非糖尿病成年人葡萄糖代谢的协同作用。
Psychother Psychosom. 2012;81(5):327-8. doi: 10.1159/000337413. Epub 2012 Aug 1.
8
World Congress on Insulin Resistance, Diabetes, and Cardiovascular Disease: part 2.胰岛素抵抗、糖尿病与心血管疾病世界大会：第2部分
Diabetes Care. 2011 Aug;34(8):e126-31. doi: 10.2337/dc11-0936.
本文引用的文献
1
Insulin concerns and promises.胰岛素：相关问题与前景
Diabetes Care. 2011 Jun;34(6):e100-6. doi: 10.2337/dc11-0591.
2
Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes.位于 ATM 附近的常见变异与 2 型糖尿病患者使用二甲双胍的血糖反应有关。
Nat Genet. 2011 Feb;43(2):117-20. doi: 10.1038/ng.735. Epub 2010 Dec 26.
3
The effect of fructose on renal biology and disease.果糖对肾脏生物学和疾病的影响。
J Am Soc Nephrol. 2010 Dec;21(12):2036-9. doi: 10.1681/ASN.2010050506. Epub 2010 Nov 29.
4
Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis.二甲双胍与糖尿病患者的癌症风险：系统评价和荟萃分析。
Cancer Prev Res (Phila). 2010 Nov;3(11):1451-61. doi: 10.1158/1940-6207.CAPR-10-0157. Epub 2010 Oct 12.
5
Metformin prevents tobacco carcinogen--induced lung tumorigenesis.二甲双胍可预防烟草致癌物诱导的肺癌发生。
Cancer Prev Res (Phila). 2010 Sep;3(9):1066-76. doi: 10.1158/1940-6207.CAPR-10-0055. Epub 2010 Sep 1.
6
Chemoprevention meets glucose control.化学预防与血糖控制相结合。
Cancer Prev Res (Phila). 2010 Sep;3(9):1049-52. doi: 10.1158/1940-6207.CAPR-10-0178. Epub 2010 Sep 1.
7
Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5.抗糖尿病药物通过 Cdk5 抑制肥胖相关的 PPARγ磷酸化。
Nature. 2010 Jul 22;466(7305):451-6. doi: 10.1038/nature09291.
8
Metformin suppresses azoxymethane-induced colorectal aberrant crypt foci by activating AMP-activated protein kinase.二甲双胍通过激活 AMP 激活的蛋白激酶抑制氧化偶氮甲烷诱导的结直肠隐窝异常。
Mol Carcinog. 2010 Jul;49(7):662-71. doi: 10.1002/mc.20637.
9
Glucose-lowering agents and cancer mortality rates in type 2 diabetes: assessing effects of time-varying exposure.降糖药物与 2 型糖尿病患者的癌症死亡率：评估时变暴露的影响。
Diabetologia. 2010 Aug;53(8):1631-7. doi: 10.1007/s00125-010-1750-8. Epub 2010 Apr 21.
10
Metformin inhibits aromatase expression in human breast adipose stromal cells via stimulation of AMP-activated protein kinase.二甲双胍通过激活 AMP 激活的蛋白激酶抑制人乳腺脂肪基质细胞中芳香化酶的表达。
Breast Cancer Res Treat. 2010 Sep;123(2):591-6. doi: 10.1007/s10549-010-0834-y. Epub 2010 Mar 19.
Zotero 插件